Journey Medical (DERM): Price to Sales

Corporate company logo of Journey Medical Corp. (DERM)

Steady demand for approved dermatological brands at Journey Medical (DERM) ensures sustainable revenue, as reflected in the company's P/S ratio dynamics, where the indicator reaches 1.40. The optimization of regional warehouses supports retail profitability by preventing drug shortages. Simultaneously, the business minimizes its environmental footprint through plastic recycling and strict compliance with waste disposal regulations.

Price-to-Revenue Ratio: Journey Medical Corp (DERM) for 07/04/2022 - 11/13/2026

Analytical breakdowns for Journey Medical (DERM)

- stock quotes and analyst forecast:
Price journeymedicalcorp.com|DERM - Price Target Chart
- stock exchange capitalization data:
Market Value Journey Medical Corp.|DERM - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Journey Medical|DERM - Company Book Value|Market Value to Book Value journeymedicalcorp.com|DERM - Aggregate Company Assets
- business debt structure and liquidity details:
Debt to Equity Ratio Journey Medical|DERM - Long-Term Debt to Capital|Current Liabilities to Capital journeymedicalcorp.com|DERM - Company Total Debt|Debts to Book Value Journey Medical Corp.|DERM - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Journey Medical|Quick Liquidity Indicator journeymedicalcorp.com
- company profitability and valuation multiples indicators:
DERM - Net Profit|Expected Net Profit Journey Medical|DERM - P/E Multiple|Price to Future Earnings Ratio journeymedicalcorp.com|DERM - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Journey Medical Corp.|DERM - Operating profit EBITDA|Net earnings per share for the last 12 months Journey Medical|DERM - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth journeymedicalcorp.com|DERM - Earnings per share growth in current year|Net earnings per share growth forecast for next year Journey Medical
- total revenue and sales volume data:
DERM - Revenue and Sales Volume|Company Revenue Forecast journeymedicalcorp.com|DERM - P/S Multiple|Market Cap to Future Revenue Ratio Journey Medical Corp.
Summary company analytics:DERM - Journey Medical Corp
Manufactured products of Journey Medical Corp.

The operating model of Journey Medical (DERM) is reflected in the shifting P/S multiple amid geopolitical risks and substance supply chain disruptions. This indicator compares market capitalization to annual revenue, allowing investors to assess the premium paid for the asset and the business value's sensitivity to external shocks, excluding debt load or accounting distortions.

Who Journey Medical competes with

Market Cap to Sales Volume KRYS|Price-to-Revenue Ratio Apogee Therapeutics, Inc. APGE|Arcutis (ARQT) - Price to Sales|VCEL: Market Cap to Revenue|ORKA - P/S Multiple|sanaramedtech.com (SMTI) - Price-to-Revenue Ratio|DBV Technologies - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Solesence Beauty|Market Cap to Revenue Ratio FBRX (Forte Biosciences Inc.)|P/S Multiple EMPG|SLGL - Price to Sales|AXIL Brands - Market Cap to Revenue|medicuspharma.com (MDCX) - Price to Sales|VRCA: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio HOTH (Hoth Therapeutics, Inc.)|biofrontera-us.com (BFRI) - Price-to-Revenue Ratio|Market Cap to Revenue VYNE Therapeutics Inc.|SNOA (Sonoma Pharmaceuticals Inc.) - P/S Multiple|Price to Sales Quoin Pharma QNRX|P/S Multiple AZTR|Dermata Therapeutics Inc - Market Cap to Revenue Ratio|P/S Multiple ELAB (Elevai Skincare)|Price-to-Revenue Coefficient Revance Therapeutics Inc (RVNC)